Drug-Eluting Stents Unlikely To Dramatically Reduce CABG Demand – ECRI
Increased use of drug-eluting stents will not significantly erode the number of coronary artery bypass surgeries (CABG) performed, according to an ECRI technology assessment
Increased use of drug-eluting stents will not significantly erode the number of coronary artery bypass surgeries (CABG) performed, according to an ECRI technology assessment